Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells

Endocrinology

Volumn 152, Issue 6, 2011, Pages 2150-2163

  Hu, Wen Yang ^a   Shi, Guang Bin ^a   Lam, Hung Ming ^b   Hu, Dan Ping ^a   Ho, Shuk Mei ^b   Madueke, Ikenna C ^a   Kajdacsy Balla, Andre ^a   Prins, Gail S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL MARKER; CELL NUCLEUS ANTIGEN; CYTOKERATIN 18; CYTOKERATIN 8; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; PROTEIN P63; TESTOSTERONE;

ADENOCARCINOMA; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CELL CLONE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOLOGY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY CAPSULE; KIDNEY INTERSTITIUM; LONGITUDINAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; RAT; STAINING; STEM CELL;

ADULT; ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EPITHELIUM; ESTROGENS; HUMANS; MALE; MICE; MICE, NUDE; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; YOUNG ADULT;

EID: 79956152315     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1377     Document Type: Article

References (80)

1. Prins GS 1997 Developmental estrogenization of the prostate gland. In: Naz RK, ed. Prostate: basic and clinical aspects. Chap 10. Boca Raton, FL:CRC Press; 247-265
2. Prins GS, Birch L, Tang WY, Ho SM 2007 Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 23:374-382 (Pubitemid 46602925)
3. Prins GS, Korach KS 2008 The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73:233-244
4. Ellem SJ, Risbridger GP 2007 Treating prostate cancer: a rationale for targeting local oestrogens. Nat Rev 7:621-627 (Pubitemid 47108185)
5. Leung YK, Lam HM, Wu S, Song D, Levin L, Cheng L, Wu CL, Ho SM 2010 Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocr-Relat Cancer 17:675-689
6. Pienta KJ, Abate-Shen C, Agus DB, Attar RM, Chung LW, Greenberg NM, Hahn WC, Isaacs JT, Navone NM, Peehl DM, Simons JW, Solit DB, Soule HR, VanDyke TA, Weber MJ, Wu L, Vessella RL 2008 The current state of preclinical prostate cancer animal models. Prostate 68:629-639 (Pubitemid 351614641)
7. De Marzo AM, Coffey DS, Nelson WG 1999 New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology 53:29-42
8. Shirai T, Takahashi S, Cui L, Futakuchi M, Kato K, Tamano S, Imaida K 2000 Experimental prostate carcinogenesis-rodent models. Mutat Res 462:219-226
9. Gabril MY, Duan W, Wu G, Moussa M, Izawa JI, Panchal CJ, Sakai H, Xuan JW 2005 A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies. Mol Ther 11:348-362 (Pubitemid 40277311)
10. Asamoto M, Hokaiwado N, Cho YM, Takahashi S, Ikeda Y, Imaida K, Shirai T 2001 Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent. Cancer Res 61:4693-4700 (Pubitemid 32691878)
11. Pollard M, Luckert PH 1986 Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone. J Natl Cancer Inst 77:583-587 (Pubitemid 16039411)
12. Slayter MV, Anzano MA, Kadomatsu K, Smith JM, Sporn MB 1994 Histogenesis of induced prostate and seminal vesicle carcinoma in Lobund-Wistar rats: a system for histological scoring and grading. Cancer Res 54:1440-1445
13. Dunning W 1963 Prostate cancer in the rat. In: Vollmer E, ed. Biology of the prostae and related tissues. Bethesda, MD: National Cancer Institute; 351-364
14. Noble RL 1980 Production of Nb rat carcinomas of the dorsal prostate and response of estrogen-dependent transplants to sex hormones and tamoxifen. Cancer Res 40:3547-3550 (Pubitemid 10003747)
15. Zhao H, Nolley R, Chen Z, Peehl DM 2010 Tissue slice grafts: an in vivo model of human prostate androgen signaling. Am J Pathol 177:229-239
16. Gleave ME, Hsieh JT, Wu HC, von Eschenbach AC, Chung LW 1992 Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res 52:1598-1605
17. Sobel RE, Sadar MD 2005 Cell lines used in prostate cancer research: a compendium of old and new lines-part 1. J Urol 173:342-359
18. Corey E, Quinn JE, Buhler KR, Nelson PS, Macoska JA, True LD, Vessella RL 2003 LuCaP 35: a new model of prostate cancer progression to androgen independence. Prostate 55:239-246 (Pubitemid 36618182)
19. Presnell SC, Petersen B, Heidaran M 2002 Stem cells in adult tissues. Semin Cell Dev Biol 13:369-376 (Pubitemid 35300814)
20. Beachy PA, Karhadkar SS, Berman DM 2004 Tissue repair and stem cell renewal in carcinogenesis. Nature 432:324-331 (Pubitemid 39551660)
21. Smith S, Neaves W, Teitelbaum S 2007 Adult versus embryonic stem cells: treatments. Science 316:1422-1423
22. Kasper S 2008 Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev 4:193-201
23. Miki J, Rhim J 2008 Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells. Prostate Cancer P D 11:32-39 (Pubitemid 351250327)
24. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE 2010 Control of mammary stem cell function by steroid hormone signalling. Nature. 465:798-802
25. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R 2010 Progesterone induces adult mammary stem cell expansion. Nature. 465:803-807
26. Gu G, Yuan J, Wills M, Kasper S 2007 Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67:4708-4715
27. Leong KG, Wang BE, Johnson L, Gao WQ 2008 Generation of a prostate from a single cell. Nature 456:804-808
28. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT 2008 The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 68:9703-9711
29. Isaacs JT, Coffey DS 1989 Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 2:33-50 (Pubitemid 20075619)
30. Lang SH, Stark M, Collins A, Paul AB, Stower MJ, Maitland NJ 2001 Experimental prostate morphogenesis in response to stroma and three dimensional matrigel culture. Cell Growth Differ 12:631-640 (Pubitemid 34084116)
31. Goldstein AS, Lawson DA, Cheng D, Sun W, Garraway IP, Witte ON 2008 Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA 105:20882-20887
32. Garraway IP, Sun W, Tran CP, Perner S, Zhang B, Goldstein AS, Hahm SA, Haider M, Head CS, Reiter RE, Rubin MA, Witte ON 2010 Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. Prostate 70:491-501
33. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON 2007 Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 25:2760-2769 (Pubitemid 350127860)
34. Goldstein AS, Stoyanova T, Witte ON 2010 Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate-cancer initiating cells. Mol Oncol 4:385-396
35. Taylor RA, Cowin PA, Cunha GR, Pera M, Trounson AO, Pedersen J, Risbridger GP 2006 Formation of human prostate tissue from embryonic stem cells. Nat Methods 3:179-181
36. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR 2001 Malignant transformation in a non-tumorigenic human prostatic epithelial cell line. Cancer Res 61:8135-8142 (Pubitemid 33091604)
37. Ricke W, Ishii K, Ricke EA, Simko J, Wang Y, Hayward SW, Cunha GR 2006 Steroid hormones stimulate human prostate cancer progression and metastasis. Int J Cancer 52 118:2123-2131
38. Noble RL 1977 The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 37:1929-1933 (Pubitemid 8095214)
39. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS 2006 Developmental exposure estradiol and bisphenol A (BPA) increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant (PDE4D4) in the rat prostate. Cancer Res 66:5624-5632 (Pubitemid 43927114)
40. Lang SH, Smith J, Hyde C, Macintosh C, Stower MJ, Maitland NJ 2006 Differentiation of prostate epithelial cell cultures by matrigel/ stromal cell glandular reconstruction. In Vitro Cell Dev Biol 42:273-280 (Pubitemid 44851885)
41. Lukacs RU, Goldstein AS, Lawson DA, Cheng D, Witte ON 2010 Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 5:702-713
42. Cunha G, Lung B, Reese B 1980 Glandular epithelial induction by embryonic mesenchyme in adult bladder epithelium of Balb/C mice. J Invest Urol 17:302-304 (Pubitemid 10094034)
43. Huang L, Pu Y, Hu WY, Birch L, Luccio-Camelo DC, Yamaguchi TP, Prins GS 2009 The role of Wnt5a in prostate gland development. Dev Biol 358:188-199
44. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT 2004 CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117:3539-3545 (Pubitemid 39206394)
45. Draper JS, Pigott C, Thomson JA, Andrews PW 2002 Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200:249-258 (Pubitemid 34467317)
46. Price D 1936 Normal development of the prostate and seminal vesicles of the rat with a study of experimental postnatal modifications. Am J Anat 60:79-127
47. Coffey D, Walsh P 1990 Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin No Am 17:461-475 (Pubitemid 20220190)
48. Levine AC, Kirschenbaum A, Droller M, Gabrilove JL 1991 Effect of the addition of estrogen to medical castration on prostatic size, symptoms, histology and serum prostate specific antigen in 4 men with benign prostatic hypertrophy. J Urology 146:790-793
49. IARC 1992 Postmenopausal estrogen therapy. IARC Monog 72:399-530
50. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I 2002 Estradiol in elderly men. Aging Male 5:98-102
51. Cussenot O, Azzouzi AR, Nicolaiew N, Fromont G, Mangin P, Cormier L, Fournier G, Valeri A, Larre S, Thibault F, Giordanella JP, Pouchard M, Zheng Y, Hamdy FC, Cox A, Cancel-Tassin G 2007 Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. J Clin Oncol 25:3596-3602 (Pubitemid 47376605)
52. Carruba G 2007 Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. J Cell Biochem 102:899-911 (Pubitemid 350036930)
53. Montgomery RB, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS 2008 Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration- resistant tumor growth. Cancer Res 68:4447-4454
54. Leav I, Merk FB, Kwan PW, Ho SM 1989 Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate 15:23-40 (Pubitemid 20214349)
55. Bosland MC, Ford H, Horton L 1995 Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague- Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17b or diethylstilbestrol. Carcinogenesis 16:1311-1317
56. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P 1995 Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim. 31:14-24
57. Chan QK, Lam HM, Ng CF, Lee AY, Chan ES, Ng HK, Ho SM, Lau KM 2010 Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ 17:1511-1523
58. Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM, Mercurio AM 2010 ERβ impedes prostate cancer EMT by destabilizing HIF-1α and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 17:319-332
59. Prins GS, Birch L 1997 Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 138:1801-1809 (Pubitemid 27180792)
60. Prins GS, Marmer M, Woodham C, Chang W, Kuiper G, Gustafsson JA, Birch L 1998 Estrogen receptor-b messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139:874-883 (Pubitemid 28510101)
61. Huang L, Pu Y, Alam S, Birch L, Prins GS 2005 The role of Fgf10 signaling in branching morphogenesis and gene expression in the rat prostate gland: lobe-specific supression by neonatal estrogens. Dev Biol 278:396-414 (Pubitemid 40175038)
62. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON 2010 Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc natl SAcad Sci USA 107:2610-2615
63. Cavalieri EL, Rogan EG 2010 Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncol 6:75-91
64. Tam NN, Leav I, Ho SM 2007 Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. Am J Pathol 171:1334-1341 (Pubitemid 47582906)
65. Lane KE, Leav I, Ziar J, Bridges RS, Rand WM, Ho SM 1997 Suppression of testosterone and estradiol-17β-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Carcinogenesis 18:1505-1510 (Pubitemid 28134772)
66. Gilleran JP, Putz O, DeJong M, DeJong S, Birch L, Pu Y, Huang L, Prins GS 2003 The role of prolactin in the prostatic inflammatory response to neonatal estrogen. Endocrinology 144:2046-2054 (Pubitemid 36543345)
67. Tam NN, Szeto CY, Freudenberg JM, Fullenkamp AN, Medvedovic M, Ho SM 2010 Research resource: estrogen-driven prolactin- mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia. Mol Endocrinol 11:2207-2217
68. Dagvadorj A, Kirken RA, Leiby B, Karras J, Nevalainen MT 2008 Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo. Clin Cancer Res 14:1317-1324 (Pubitemid 351413910)
69. Rouet V, Bogorad RL, Kayser C, Kessal K, Genestie C, Bardier A, Grattan DR, Kelder B, Kopchick JJ, Kelly PA, Goffin V 2010 Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors. Proc Natl Acad Sci USA 107:15199-15204
70. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON 2010 Identification of a cell of origin for human prostate cancer. Science 329:568-571
71. Prins GS, Birch L, Habermann H, Chang WY, Tebeau C, Putz O, Bieberich C 2001 Influence of neonatal estrogens on rat prostate development. Reprod Fertil Dev 13:241-252 (Pubitemid 33133343)
72. Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B, Korach KS 2001 Estrogen imprinting of the developing prostate gland in mediated through stromal estrogen receptor a: studies with aERKO and bERKO mice. Canc Res 61:6089-6097 (Pubitemid 32762544)
73. Prins GS, Ho SM 2010 Early life estrogens and prostate cancer in an animal model. J Dev Origins Health Dis 1:365-370
74. Maitland NJ, Collins AT 2008 Prostate cancer stem cells: a new target for therapy. J Clin Oncol 26:2862-2870
75. Price D, Stein B, Sieber P, Tutrone R, Bailen J, Goluboff E, Burzon D, Bostwick D, Steiner M 2006 Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neo- plasia: results of a double-blind, placebo controlled, phase IIB clinical trial. J Urol 176:965-970
76. Nonn L, Ananthanarayanan V, Gann PH 2009 Evidence for field cancerization of the prostate. Prostate 69:1470-1479
77. Chu JH, Yu S, Hayward SW, Chan FL 2009 Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer. Prostate 69:428-442
78. Dubrovska A, Kim S, Salamone RJ, Walker JR, Maira SM, García-Echeverría C, Schultz PG, Reddy VA 2009 The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA 106:269-273
79. Bisson I, Prowse DM 2009 Wnt signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 19:683-697
80. Vander Griend DJ, Konishi Y, De Marzo AM, Isaacs JT, Meeker AK 2009 Dual-label centromere and telomere FISH identifies human, rat, and mouse cell contribution to multispecies recombinant urogenital sinus xenografts. Prostate 69:1557-1564